Tenofovir: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
(chem infobox)
imported>Caesar Schinas
m (Bot: Replacing medical templates with CZMed)
Line 34: Line 34:
   
   
== External links ==
== External links ==
* {{DailyMed}}
{{CZMed}}
* {{MedMaster}}
* {{DrugBank}}

Revision as of 01:21, 3 June 2009

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
Tenofovir structure.jpg
tenofovir
IUPAC name: see chemistry section
Synonyms: TDF, PMPA
Formula: C9H14N5O4P

 Uses: HIV/AIDS & Hep. B

 Properties: RT inhibitor, adenosine analog

 Hazards: see drug interactions

Mass (g/mol): CAS #:
287.2123 147127-20-6


Tenofovir is a nucleotide analog reverse transcritase inhibitor (nRTI) antiviral drug used to treat HIV/AIDS and is in clinical trials for treatment of hepatitis B infection. The triphosphate from of the drug competes with the natural DNA nucleotide deoxyadenosine triphosphate (dATP) during DNA formation and it acts as a DNA chain terminator once incorporated because it lacks the normal deoxyribose sugar needed for connecting to the next DNA base.

Chemistry

The IUPAC chemical name for tenofovir is [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid and it has chemical formula C9H14N5O4P, giving it a molecular mass of 287.2123 g/mol. It is chemically similar to the natural neucleotide adenosine but lacks a ribose sugar unit.

Synonyms and brand names

Synonyms

  • Tenofovir disoproxil
  • Tenofovir disoproxil fumarate
  • D,L-Tenofovir
  • TDF
  • PMPA

Brand Names

  • Apropovir
  • Viread

External links

The most up-to-date information about Tenofovir and other drugs can be found at the following sites.